A 48-year-old man presents with DKA. Initial treatment is initiated with fluids and insulin infusion. Labs show glucose 460 mg/dL, pH 7.18, bicarbonate 10 mEq/L, potassium 4.5 mEq/L, and creatinine 2.8 mg/dL (baseline 1.0). After 4 hours, glucose decreases to 380 mg/dL but pH worsens to 7.12, bicarbonate drops to 8 mEq/L, and lactate is 5.2 mmol/L (initially 1.8). Blood pressure is 85/50 mmHg. Evaluate the clinical situation and necessary intervention.
Q2
A 25-year-old woman with type 1 diabetes presents with DKA. She admits to intentionally withholding insulin to lose weight. This is her fifth DKA admission in 8 months. Current pH is 7.14, glucose 520 mg/dL, bicarbonate 11 mEq/L. Medical costs exceed $150,000 for recurrent admissions. The team is frustrated. Evaluate the comprehensive management approach beyond acute DKA treatment.
Q3
A 55-year-old man with type 2 diabetes and end-stage renal disease on hemodialysis presents with DKA. Initial glucose is 580 mg/dL, pH 7.12, bicarbonate 10 mEq/L, and potassium 6.2 mEq/L. He is fluid overloaded with bilateral crackles and peripheral edema. His last dialysis was 3 days ago. Evaluate the optimal management strategy addressing both DKA and renal failure.
Q4
A 38-year-old pregnant woman at 28 weeks gestation with type 1 diabetes presents with nausea and vomiting. Labs show glucose 310 mg/dL, pH 7.27, bicarbonate 15 mEq/L, and positive urine ketones. Fetal monitoring shows reactive non-stress test. She has been taking her insulin but unable to eat for 24 hours due to hyperemesis. Analyze the optimal management approach considering maternal and fetal risks.
Q5
A 42-year-old man with type 1 diabetes on insulin pump presents with DKA after pump malfunction. He is admitted and started on IV insulin infusion. After 14 hours of treatment, his glucose is 210 mg/dL on D5-0.45% saline, pH 7.36, bicarbonate 19 mEq/L, and anion gap 12. He is alert, eating, and requesting to go home. Evaluate the appropriate transition strategy.
Q6
A 52-year-old woman with type 2 diabetes is admitted for DKA. Initial pH is 7.08, bicarbonate 8 mEq/L, and anion gap 28. She is started on standard DKA protocol. After 10 hours of treatment, her glucose is 180 mg/dL, pH is 7.28, bicarbonate is 14 mEq/L, but anion gap remains elevated at 22. Chloride is 115 mEq/L (elevated). Analyze the acid-base status.
Q7
A 35-year-old man with type 1 diabetes presents with DKA. Initial labs show pH 6.95, bicarbonate 6 mEq/L, glucose 610 mg/dL, and potassium 5.8 mEq/L. After starting standard DKA protocol with fluids and insulin, he develops altered mental status and seizures 3 hours into treatment. CT head is unremarkable. Analyze the most likely complication.
Q8
A 28-year-old woman with type 1 diabetes is being treated for DKA. After 6 hours of treatment with IV fluids and insulin infusion, her glucose is 240 mg/dL, pH 7.31, bicarbonate 16 mEq/L, and anion gap 18. She is alert and tolerating oral intake. Apply the appropriate modification to her treatment regimen.
Q9
A 45-year-old man with type 2 diabetes is admitted for DKA. After initial fluid resuscitation, his vital signs are stable. Current glucose is 480 mg/dL, pH 7.22, bicarbonate 12 mEq/L, and potassium 3.2 mEq/L. Apply the appropriate next management step.
Q10
A 19-year-old woman with type 1 diabetes presents to the emergency department with nausea, vomiting, and abdominal pain for 12 hours. Vital signs show BP 95/60 mmHg, HR 115/min, RR 28/min, and temperature 37.2°C. Laboratory results show glucose 520 mg/dL, pH 7.18, bicarbonate 10 mEq/L, and positive serum ketones. Apply the initial fluid resuscitation protocol for this patient.
DKA US Medical PG Practice Questions and MCQs
Question 1: A 48-year-old man presents with DKA. Initial treatment is initiated with fluids and insulin infusion. Labs show glucose 460 mg/dL, pH 7.18, bicarbonate 10 mEq/L, potassium 4.5 mEq/L, and creatinine 2.8 mg/dL (baseline 1.0). After 4 hours, glucose decreases to 380 mg/dL but pH worsens to 7.12, bicarbonate drops to 8 mEq/L, and lactate is 5.2 mmol/L (initially 1.8). Blood pressure is 85/50 mmHg. Evaluate the clinical situation and necessary intervention.
A. Administer additional fluid bolus for persistent hypotension
B. Evaluate for sepsis or other concurrent illness causing lactic acidosis (Correct Answer)
C. Increase insulin infusion rate to accelerate ketone clearance
D. Add bicarbonate therapy for worsening acidosis
E. Continue current management as DKA takes time to resolve
Explanation: ***Evaluate for sepsis or other concurrent illness causing lactic acidosis***
- While the blood glucose is responding to insulin, the **worsening metabolic acidosis** and significantly elevated **lactate (5.2 mmol/L)** indicate a secondary process such as **sepsis** or tissue hypoperfusion.
- **Diabetic Ketoacidosis (DKA)** often has a precipitating factor; the combination of **hypotension** and rising lactate suggests **septic shock** or organic ischemia that requires urgent investigation and targeted treatment.
*Administer additional fluid bolus for persistent hypotension*
- Although fluid resuscitation is vital, simply giving more fluids without diagnosing the **underlying cause** of the rising lactate and refractory shock is insufficient.
- **Hypotension** in this context may be secondary to **septic shock** or systemic inflammatory response rather than simple volume depletion from DKA.
*Increase insulin infusion rate to accelerate ketone clearance*
- The current insulin infusion is successfully lowering the blood glucose, but the acidosis is worsening due to **lactic acid**, not just ketones.
- Increasing insulin will not resolve **Type A lactic acidosis** caused by **inadequate tissue oxygenation** or sepsis.
*Add bicarbonate therapy for worsening acidosis*
- **Bicarbonate therapy** is generally not recommended in DKA unless the pH is <6.9, as it can cause **paradoxical cerebral acidosis** and hypokalemia.
- Administering bicarbonate would provide a temporary buffer but would fail to address the **rising lactate** and underlying hemodynamic instability.
*Continue current management as DKA takes time to resolve*
- While DKA resolution is gradual, a **rising lactate** and **falling pH** despite therapy are red flags that indicate the clinical condition is deteriorating.
- Ignoring the **acute kidney injury** (Creatinine 2.8) and persistent **hypotension** increases the risk of multi-organ failure and mortality.
Question 2: A 25-year-old woman with type 1 diabetes presents with DKA. She admits to intentionally withholding insulin to lose weight. This is her fifth DKA admission in 8 months. Current pH is 7.14, glucose 520 mg/dL, bicarbonate 11 mEq/L. Medical costs exceed $150,000 for recurrent admissions. The team is frustrated. Evaluate the comprehensive management approach beyond acute DKA treatment.
A. Referral to ethics committee for discussion of resource allocation
B. Involuntary psychiatric commitment for non-compliance
C. Insulin pump placement to prevent future manipulation
D. Multidisciplinary approach including psychiatry, eating disorder specialist, diabetes educator, and close outpatient follow-up (Correct Answer)
E. Standard DKA treatment with discharge to outpatient endocrinology
Explanation: ***Multidisciplinary approach including psychiatry, eating disorder specialist, diabetes educator, and close outpatient follow-up***
- This patient presents with **diabulimia**, a life-threatening eating disorder where Type 1 diabetics restrict insulin for weight control, requiring a **comprehensive care team** to address both physiologic and psychological needs.
- A **multidisciplinary strategy** is essential to reduce the high risk of mortality and frequent **recurrent DKA admissions** by targeting the root cause of non-compliance.
*Referral to ethics committee for discussion of resource allocation*
- While medical costs are high, **withholding treatment** based on cost or resource allocation for a life-threatening condition like DKA is generally unethical.
- The **ethics committee** may assist in complex care plans, but it does not address the primary clinical need for specialized psychiatric and nutritional intervention.
*Involuntary psychiatric commitment for non-compliance*
- **Involuntary commitment** typically requires the patient to be a danger to themselves or others due to a mental illness; insulin omission, while dangerous, often does not meet legal criteria if the patient has **decision-making capacity**.
- Simple **non-compliance** in an adult with capacity is not usually grounds for commitment, and long-term behavioral change is better achieved through voluntary therapeutic engagement.
*Insulin pump placement to prevent future manipulation*
- An **insulin pump** is not a solution as it can still be easily manipulated, disconnected, or the settings altered by a patient determined to restrict insulin.
- Introducing a medical device without addressing the **underlying eating disorder** may actually complicate management and increase the risk of device-related complications.
*Standard DKA treatment with discharge to outpatient endocrinology*
- Given five DKA admissions in 8 months, standard management has already proven **insufficient** and fails to address the unique psychiatric etiology of her condition.
- Discharging to **standard outpatient endocrinology** without specialized eating disorder support ignores the behavioral triggers that lead to recurrent life-threatening metabolic crises.
Question 3: A 55-year-old man with type 2 diabetes and end-stage renal disease on hemodialysis presents with DKA. Initial glucose is 580 mg/dL, pH 7.12, bicarbonate 10 mEq/L, and potassium 6.2 mEq/L. He is fluid overloaded with bilateral crackles and peripheral edema. His last dialysis was 3 days ago. Evaluate the optimal management strategy addressing both DKA and renal failure.
A. Standard DKA protocol with furosemide for fluid management
B. Bicarbonate therapy to correct acidosis without fluids
C. Subcutaneous insulin with no IV fluids due to volume overload
D. Insulin infusion with limited fluids and urgent hemodialysis (Correct Answer)
E. Standard DKA protocol with aggressive fluid resuscitation
Explanation: ***Insulin infusion with limited fluids and urgent hemodialysis***
- Patients with **ESRD** and **DKA** who are **fluid overloaded** require **urgent hemodialysis** to safely correct metabolic acidosis, hyperkalemia, and volume status.
- **Continuous insulin infusion** is essential to stop ketone production, but fluid resuscitation must be severely **restricted** to avoid worsening pulmonary edema.
*Standard DKA protocol with furosemide for fluid management*
- **Furosemide** is ineffective in patients with **end-stage renal disease** (ESRD) as they have minimal to no residual renal function.
- Standard DKA protocols prioritize aggressive IV fluids, which would be **life-threatening** for a patient already showing signs of volume overload and crackles.
*Bicarbonate therapy to correct acidosis without fluids*
- **Bicarbonate therapy** is generally not recommended for DKA unless the pH is below 6.9, and it can cause a **rebound worsening** of intracellular acidosis.
- It does not address the underlying **insulin deficiency** or the patient's massive **volume overload** and hyperkalemia.
*Subcutaneous insulin with no IV fluids due to volume overload*
- **Subcutaneous insulin** is inappropriate for severe DKA (pH 7.12); **intravenous insulin** is the standard for rapid titration and metabolic control.
- Complete avoidance of fluids may prevent correction of the **osmotic shift**, but the primary failure here is the omission of dialysis for a symptomatic ESRD patient.
*Standard DKA protocol with aggressive fluid resuscitation*
- Aggressive fluid administration is **contraindicated** in ESRD patients with clinical signs of **congestive heart failure** like crackles and peripheral edema.
- This approach carries a high risk of inducing **acute respiratory failure** or flash pulmonary edema.
Question 4: A 38-year-old pregnant woman at 28 weeks gestation with type 1 diabetes presents with nausea and vomiting. Labs show glucose 310 mg/dL, pH 7.27, bicarbonate 15 mEq/L, and positive urine ketones. Fetal monitoring shows reactive non-stress test. She has been taking her insulin but unable to eat for 24 hours due to hyperemesis. Analyze the optimal management approach considering maternal and fetal risks.
A. Standard DKA protocol with standard glucose targets (200-250 mg/dL)
B. Aggressive DKA treatment with lower glucose targets (100-150 mg/dL) and close fetal monitoring (Correct Answer)
C. Immediate cesarean delivery followed by DKA treatment
D. Conservative management with oral intake and subcutaneous insulin
E. Standard DKA protocol with delivery planning after stabilization
Explanation: ***Aggressive DKA treatment with lower glucose targets (100-150 mg/dL) and close fetal monitoring***
- In pregnancy, **Diabetic Ketoacidosis (DKA)** often presents with lower blood glucose levels due to increased **glucose utilization** by the fetus and placenta.
- Successful management requires **aggressive hydration**, **intravenous insulin**, and maintaining blood glucose between **100-150 mg/dL** to prevent fetal complications.
*Standard DKA protocol with standard glucose targets (200-250 mg/dL)*
- Standard targets for non-pregnant adults are too high for pregnancy and can lead to prolonged **fetal acidosis** and increased morbidity.
- Pregnancy-specific protocols prioritize tighter glycemic control to optimize the **maternal-fetal environment** during acute metabolic distress.
*Immediate cesarean delivery followed by DKA treatment*
- Surgery during **untreated DKA** carries extremely high maternal and fetal risk; the fetus should only be delivered for **obstetric indications** after maternal stabilization.
- **Fetal heart rate** abnormalities often resolve once the mother's **acidosis** and electrolyte imbalances are corrected with medical therapy.
*Conservative management with oral intake and subcutaneous insulin*
- Maternal **acidemia (pH 7.27)** and **ketonuria** indicate a medical emergency that cannot be safely managed with subcutaneous insulin or oral fluids.
- **Nausea and vomiting** from hyperemesis or the DKA itself necessitate **intravenous fluid resuscitation** and specialized inpatient monitoring.
*Standard DKA protocol with delivery planning after stabilization*
- While maternal stabilization is the primary goal, following a "standard" protocol ignores the need for **lower glucose targets** unique to pregnancy.
- **Delivery planning** at 28 weeks should only be considered if fetal distress persists after maternal metabolic status has returned to baseline.
Question 5: A 42-year-old man with type 1 diabetes on insulin pump presents with DKA after pump malfunction. He is admitted and started on IV insulin infusion. After 14 hours of treatment, his glucose is 210 mg/dL on D5-0.45% saline, pH 7.36, bicarbonate 19 mEq/L, and anion gap 12. He is alert, eating, and requesting to go home. Evaluate the appropriate transition strategy.
A. Switch to subcutaneous insulin and discharge immediately
B. Stop IV insulin immediately and restart insulin pump at home
C. Continue IV insulin for another 6 hours to ensure stability
D. Give subcutaneous insulin, overlap for 1-2 hours, then stop IV insulin and observe (Correct Answer)
E. Discontinue IV insulin, discharge with oral medications
Explanation: ***Give subcutaneous insulin, overlap for 1-2 hours, then stop IV insulin and observe***
- DKA is considered resolved when the **anion gap** is <12, **bicarbonate** is ≥18, and **pH** >7.3; once resolved, transitioning to **subcutaneous insulin** is appropriate if the patient is eating.
- An **overlap period of 1-2 hours** between the administration of subcutaneous insulin and the cessation of the **IV insulin infusion** is mandatory to prevent the recurrence of ketoacidosis due to the short half-life of IV insulin.
*Switch to subcutaneous insulin and discharge immediately*
- While the transition to subcutaneous insulin is correct, **immediate discharge** is unsafe as the patient must be observed for metabolic stability after the transition.
- Adequate time must be allowed for **absorption of subcutaneous insulin** and verification that the patient can maintain glycemic control while off the infusion.
*Stop IV insulin immediately and restart insulin pump at home*
- Stopping IV insulin **immediately** without an overlap period leads to a rapid decline in serum insulin levels and risks a **rebound of ketosis**.
- Relying on the patient to restart a potentially **malfunctioning pump** at home without inpatient supervision increases the risk of treatment failure.
*Continue IV insulin for another 6 hours to ensure stability*
- **Prolonging IV insulin** after the resolution of DKA and normalization of the anion gap is unnecessary and increases the risk of **hypoglycemia** and **hypokalemia**.
- Since the patient is alert and **eating**, they meet the criteria for transitioning to a subcutaneous regimen to facilitate a return to normal metabolic management.
*Discontinue IV insulin, discharge with oral medications*
- **Type 1 diabetic** patients have an absolute insulin deficiency and always require exogenous insulin; **oral medications** are inappropriate for managing T1DM.
- Discontinuing insulin therapy in a T1DM patient will inevitably lead to the return of **hyperglycemia** and life-threatening **diabetic ketoacidosis**.
Question 6: A 52-year-old woman with type 2 diabetes is admitted for DKA. Initial pH is 7.08, bicarbonate 8 mEq/L, and anion gap 28. She is started on standard DKA protocol. After 10 hours of treatment, her glucose is 180 mg/dL, pH is 7.28, bicarbonate is 14 mEq/L, but anion gap remains elevated at 22. Chloride is 115 mEq/L (elevated). Analyze the acid-base status.
A. Renal tubular acidosis unmasked by treatment
B. Mixed anion gap and non-anion gap acidosis (Correct Answer)
C. Persistent DKA requiring increased insulin rate
D. Non-anion gap metabolic acidosis from excessive saline administration
E. Resolving DKA with appropriate response to treatment
Explanation: ***Mixed anion gap and non-anion gap acidosis***
- The patient exhibits a **persistently elevated anion gap** (22) from incomplete clearance of ketones and a **hyperchloremic non-anion gap metabolic acidosis (NAGMA)** due to aggressive saline administration.
- The rise in **chloride to 115 mEq/L** alongside a low bicarbonate level while the pH is still acidic confirms that two distinct metabolic processes are contributing to the acidemia.
*Renal tubular acidosis unmasked by treatment*
- While **RTA** causes a non-anion gap acidosis, it is a clinical diagnosis usually associated with specific chronic electrolyte patterns or systemic diseases, not acute resuscitation settings.
- The acidosis here is better explained by the **iatrogenic chloride load** from normal saline used in standard DKA protocols.
*Persistent DKA requiring increased insulin rate*
- Although the anion gap is still elevated, the **blood glucose has significantly dropped** (180 mg/dL) and the **pH is rising**, indicating that the insulin is effectively clearing ketones.
- Increasing the insulin rate solely based on the anion gap without considering the **hyperchloremic component** could lead to hypoglycemia.
*Non-anion gap metabolic acidosis from excessive saline administration*
- While hyperchloremic NAGMA is present, this option is incomplete because it ignores the **persistent anion gap of 22**, which indicates remaining ketoacids.
- A pure NAGMA would have a **normal anion gap** (typically 8–12), which is not the case here.
*Resolving DKA with appropriate response to treatment*
- This describes the clinical trend but fails to **analyze the acid-base status** accurately as requested by the question.
- It does not account for the **elevated chloride**, which represents a secondary acid-base distraction from a simple resolving DKA profile.
Question 7: A 35-year-old man with type 1 diabetes presents with DKA. Initial labs show pH 6.95, bicarbonate 6 mEq/L, glucose 610 mg/dL, and potassium 5.8 mEq/L. After starting standard DKA protocol with fluids and insulin, he develops altered mental status and seizures 3 hours into treatment. CT head is unremarkable. Analyze the most likely complication.
A. Meningitis as precipitating factor for DKA
B. Hyperkalemia from potassium supplementation
C. Hyponatremia from excessive free water
D. Hypoglycemia from excessive insulin
E. Cerebral edema from overly rapid correction (Correct Answer)
Explanation: ***Cerebral edema from overly rapid correction***
- Rapid decline in **serum osmolality** during DKA treatment causes water to shift into brain cells, leading to **cerebral edema** and neurological deterioration.
- It typically presents with **altered mental status** and **seizures** within 4-12 hours of starting therapy; a CT scan may be **normal** in the early stages.
*Meningitis as precipitating factor for DKA*
- While infections can trigger DKA, the development of symptoms **after starting treatment** with no fever or meningeal signs makes this less likely.
- Initial labs and the rapid timeline of neurological decline suggest a **treatment-related complication** rather than a primary infection.
*Hyperkalemia from potassium supplementation*
- Although potassium is given in DKA, **hyperkalemia** typically manifests as **cardiac arrhythmias** or muscle weakness rather than seizures and acute mental status changes.
- Insulin therapy drives potassium **intracellularly**, usually necessitating supplementation to prevent hypokalemia rather than causing intoxicant-level hyperkalemia.
*Hyponatremia from excessive free water*
- While related to fluid shifts, the primary driver in DKA-associated neurological decline is the **osmotic shift** rather than simple free water excess.
- **Dilutional hyponatremia** may occur, but "cerebral edema" is the specific clinical entity used to describe this catastrophic treatment complication.
*Hypoglycemia from excessive insulin*
- **Hypoglycemia** could cause seizures, but the protocol includes adding **dextrose** to fluids once glucose reaches ~200-250 mg/dL to prevent this.
- The severity of the initial **acidosis (pH 6.95)** is a much stronger risk factor for the development of cerebral edema than for isolated hypoglycemia.
Question 8: A 28-year-old woman with type 1 diabetes is being treated for DKA. After 6 hours of treatment with IV fluids and insulin infusion, her glucose is 240 mg/dL, pH 7.31, bicarbonate 16 mEq/L, and anion gap 18. She is alert and tolerating oral intake. Apply the appropriate modification to her treatment regimen.
A. Increase insulin infusion rate to close anion gap faster
B. Decrease insulin infusion rate by 50%
C. Stop all IV fluids and insulin, transition to oral medications
D. Continue insulin infusion and add dextrose to IV fluids (Correct Answer)
E. Discontinue insulin infusion and start subcutaneous insulin
Explanation: ***Continue insulin infusion and add dextrose to IV fluids***
- When the blood **glucose** drops below **200-250 mg/dL** in DKA, **dextrose (D5W)** must be added to the IV fluids to prevent **hypoglycemia** while the **anion gap** remains open.
- Persistent **metabolic acidosis** (pH 7.31, bicarbonate 16) and an elevated **anion gap (18)** indicate that ketosis has not resolved, necessitating continued **insulin infusion** to suppress ketogenesis.
*Increase insulin infusion rate to close anion gap faster*
- Increasing the rate is unnecessary if the glucose is already dropping towards the target range; this would significantly increase the risk of rapid **hypoglycemia** and **cerebral edema**.
- The priority is to maintain a steady glucose level between **150-200 mg/dL** while the insulin stabilizes the metabolic state.
*Decrease insulin infusion rate by 50%*
- While the insulin dose may eventually be titrated, simply decreasing the rate without providing a **glucose source** does not address the primary need to close the **anion gap** while maintaining euglycemia.
- A significant reduction in insulin before the suppression of **ketone production** is complete can prolong the state of **ketoacidosis**.
*Stop all IV fluids and insulin, transition to oral medications*
- DKA protocol requires the **anion gap to close** (usually <12) and the **bicarbonate** to normalize before stopping IV insulin; here, the acidosis is still active.
- Oral agents are inappropriate for the acute management of **Type 1 Diabetes** patients in metabolic crisis.
*Discontinue insulin infusion and start subcutaneous insulin*
- Transitioning to **subcutaneous insulin** is only appropriate when the patient met all resolution criteria: **anion gap <12**, **bicarbonate ≥18**, and **pH >7.3**.
- Premature discontinuation of the IV infusion will result in a rebound of **ketosis** because the anion gap in this patient is still significantly elevated (18).
Question 9: A 45-year-old man with type 2 diabetes is admitted for DKA. After initial fluid resuscitation, his vital signs are stable. Current glucose is 480 mg/dL, pH 7.22, bicarbonate 12 mEq/L, and potassium 3.2 mEq/L. Apply the appropriate next management step.
A. Start subcutaneous insulin and continue oral intake
B. Give insulin bolus of 0.1 units/kg followed by infusion
C. Continue fluid resuscitation only until pH normalizes
D. Administer potassium replacement before starting insulin (Correct Answer)
E. Start insulin infusion at 0.1 units/kg/hour immediately
Explanation: ***Administer potassium replacement before starting insulin***
- **Insulin** causes an intracellular shift of potassium; starting it when levels are below **3.3 mEq/L** can lead to severe **hypokalemia**, cardiac arrhythmias, or respiratory failure.
- Standard **DKA protocols** mandate that potassium must be repleted until levels are above the safe threshold before initiating insulin therapy.
*Start subcutaneous insulin and continue oral intake*
- Subcutaneous insulin is generally reserved for **mild DKA** cases; severe acidosis (pH 7.22) and low bicarbonate require IV management.
- **Oral intake** is typically held until the patient is clinically stable and the **anion gap** has closed to avoid complications like vomiting or aspiration.
*Give insulin bolus of 0.1 units/kg followed by infusion*
- Administering an **insulin bolus** is contraindicated when serum potassium is **<3.3 mEq/L** due to the risk of precipitating life-threatening hypokalemia.
- Many modern guidelines actually suggest avoiding a bolus entirely in favor of an infusion to reduce the risk of **cerebral edema** and rapid electrolyte shifts.
*Continue fluid resuscitation only until pH normalizes*
- Fluids are critical, but they alone will not resolve the ketoacidosis; **insulin** is required to switch the body from a ketogenic to an anabolic state.
- **pH normalization** is a late marker of recovery, and management must address the underlying **insulin deficiency** and electrolyte imbalances simultaneously.
*Start insulin infusion at 0.1 units/kg/hour immediately*
- While insulin is the primary treatment for **DKA**, it is not the immediate priority when the patient's potassium is significantly **depleted** (3.2 mEq/L).
- Starting an infusion immediately would dangerously lower extracellular potassium levels, risking **cardiac arrest**.
Question 10: A 19-year-old woman with type 1 diabetes presents to the emergency department with nausea, vomiting, and abdominal pain for 12 hours. Vital signs show BP 95/60 mmHg, HR 115/min, RR 28/min, and temperature 37.2°C. Laboratory results show glucose 520 mg/dL, pH 7.18, bicarbonate 10 mEq/L, and positive serum ketones. Apply the initial fluid resuscitation protocol for this patient.
A. 0.9% saline at 250 mL/hour with insulin bolus
B. D5W at 150 mL/hour
C. Lactated Ringer's solution at 500 mL/hour
D. 0.9% saline at 1000-1500 mL in the first hour (Correct Answer)
E. 0.45% saline at 250 mL/hour
Explanation: ***0.9% saline at 1000-1500 mL in the first hour***
- The patient presents with **Diabetic Ketoacidosis (DKA)** and signs of severe dehydration, requiring rapid **volume expansion** with isotonic saline to restore blood pressure and perfusion.
- Initial fluid resuscitation is crucial to stabilize the patient's hemodynamic status before starting **intravenous insulin**, which could otherwise cause a shift of water into cells and worsen hypotension.
*0.9% saline at 250 mL/hour with insulin bolus*
- This rate of fluid administration is too slow for a patient with **hypotension** and **tachycardia**, as it fails to address the significant volume deficit rapidly.
- **Insulin boluses** are generally avoided in favor of a continuous infusion, and resuscitation fluids must be prioritized to prevent circulatory collapse.
*D5W at 150 mL/hour*
- **Dextrose-containing fluids** are contraindicated when the blood glucose is significantly elevated (520 mg/dL) as they will exacerbate hyperglycemia and osmotic diuresis.
- These fluids are only introduced later in the management of DKA when serum glucose drops to approximately **200-250 mg/dL** to prevent hypoglycemia.
*Lactated Ringer's solution at 500 mL/hour*
- While some evidence supports balanced crystalloids, **0.9% Normal Saline** remains the standard initial choice in acute DKA protocols for rapid volume expansion.
- A rate of 500 mL/hour is insufficient for the **initial hour** of treatment when a patient shows signs of **hypovolemic shock** or severe dehydration.
*0.45% saline at 250 mL/hour*
- **Hypotonic saline (0.45% NaCl)** is not used for initial resuscitation as it does not stay within the **intravascular compartment** effectively to restore blood pressure.
- This fluid type is typically reserved for the **maintenance phase** of DKA treatment, depending on the patient's corrected serum sodium levels after initial stabilization.
